Editor Profile

Richard T. Ellison III, MD


About the NEJM Journal Watch Infectious Diseases Board

Richard T. Ellison III, MD, is Professor of Medicine, Microbiology, and Physiological Systems in the Division of Infectious Diseases and Immunology at the University of Massachusetts Medical School, Worcester. His research interests include nosocomial infections, HIV disease, infection control, and control and treatment of infections caused by antibiotic-resistant bacteria. He has pursued basic investigations into innate host defenses against bacterial pathogens and into novel antimicrobial agents active against antibiotic-resistant bacteria. A hospital epidemiologist, Dr. Ellison has focused his investigations on treating hospital-acquired infections and HIV disease. He is a past president of the Massachusetts Infectious Diseases Society. He has written for NEJM Journal Watch Infectious Diseases and served as Deputy Editor from the publication’s launch in 1998 until becoming Editor-in-Chief in 2016.


Consultant / Advisory board

Philips Healthcare

Grant / Research support

Philips Healthcare

  • January 20, 2016

    Another Look at HCAP

    1. Richard T. Ellison III, MD

    Staphylococcus aureus and Pseudomonas aeruginosa are rarely identified as causes of healthcare-associated pneumonia.

  • January 8, 2016

    How Effective Are IV Catheter Disinfection Caps?

    1. Richard T. Ellison III, MD

    Using antiseptic barrier caps for intravenous catheter ports reduced rates of central-line–associated bloodstream infections and blood culture contamination in a high-risk cancer unit.

  • January 7, 2016

    Camels: The Reservoir for MERS-CoVs

    1. Richard T. Ellison III, MD

    An analysis of recent co-circulation of three related coronaviruses in Saudi Arabian camels, including a recombinant virus linked to human outbreaks

  • December 9, 2015

    Chikungunya Encephalitis

    1. Richard T. Ellison III, MD

    Severe encephalitis related to chikungunya infection has been reported in cases from an island in the Indian Ocean.

  • December 4, 2015

    The Risk for HCV in Hemodialysis Units

    1. Richard T. Ellison III, MD

    Two reports confirm hepatitis C transmission in hemodialysis units linked to infection control practice deficiencies.

  • November 17, 2015

    Antibiotic Susceptibility of Neisseria gonorrhoeae

    1. Richard T. Ellison III, MD

    Although national surveillance data suggest that the rise in cephalosporin resistance in N. gonorrhoeae has peaked, the improvements in susceptibility may be short-lived.